Maternal serum and amniotic fluid alpha-fetoprotein testing

our approach to screening, diagnosis and counseling.

M. C. Haven, M. Welsh, Rodney Smith Markin, W. G. Sanger

Research output: Contribution to journalArticle

Abstract

Maternal serum and amniotic fluid alpha-fetoprotein testing has increased significantly in our laboratory and throughout the state since 1985. The results of this test are reported in a novel fashion as multiples of the median. The calculation and reporting of the test results are highly dependent upon gestational age, maternal weight, race and presence or absence of maternal diabetes. When properly interpreted alpha-fetoprotein determinations are a good screening test for early detection of neural tube defects and Trisomy 21 (Down Syndrome). Our approach to screening, diagnosis and counseling is discussed.

Original languageEnglish (US)
Pages (from-to)55-58
Number of pages4
JournalThe Nebraska medical journal
Volume74
Issue number3
StatePublished - Mar 1 1989

Fingerprint

alpha-Fetoproteins
Amniotic Fluid
Down Syndrome
Counseling
Surrogate Mothers
Mothers
Neural Tube Defects
Serum
Gestational Age
Weights and Measures

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Maternal serum and amniotic fluid alpha-fetoprotein testing : our approach to screening, diagnosis and counseling. / Haven, M. C.; Welsh, M.; Markin, Rodney Smith; Sanger, W. G.

In: The Nebraska medical journal, Vol. 74, No. 3, 01.03.1989, p. 55-58.

Research output: Contribution to journalArticle

@article{a69c9c6ae04441298a656be42af0ed0d,
title = "Maternal serum and amniotic fluid alpha-fetoprotein testing: our approach to screening, diagnosis and counseling.",
abstract = "Maternal serum and amniotic fluid alpha-fetoprotein testing has increased significantly in our laboratory and throughout the state since 1985. The results of this test are reported in a novel fashion as multiples of the median. The calculation and reporting of the test results are highly dependent upon gestational age, maternal weight, race and presence or absence of maternal diabetes. When properly interpreted alpha-fetoprotein determinations are a good screening test for early detection of neural tube defects and Trisomy 21 (Down Syndrome). Our approach to screening, diagnosis and counseling is discussed.",
author = "Haven, {M. C.} and M. Welsh and Markin, {Rodney Smith} and Sanger, {W. G.}",
year = "1989",
month = "3",
day = "1",
language = "English (US)",
volume = "74",
pages = "55--58",
journal = "The Nebraska medical journal",
issn = "0091-6730",
publisher = "Nebraska State Medical Association",
number = "3",

}

TY - JOUR

T1 - Maternal serum and amniotic fluid alpha-fetoprotein testing

T2 - our approach to screening, diagnosis and counseling.

AU - Haven, M. C.

AU - Welsh, M.

AU - Markin, Rodney Smith

AU - Sanger, W. G.

PY - 1989/3/1

Y1 - 1989/3/1

N2 - Maternal serum and amniotic fluid alpha-fetoprotein testing has increased significantly in our laboratory and throughout the state since 1985. The results of this test are reported in a novel fashion as multiples of the median. The calculation and reporting of the test results are highly dependent upon gestational age, maternal weight, race and presence or absence of maternal diabetes. When properly interpreted alpha-fetoprotein determinations are a good screening test for early detection of neural tube defects and Trisomy 21 (Down Syndrome). Our approach to screening, diagnosis and counseling is discussed.

AB - Maternal serum and amniotic fluid alpha-fetoprotein testing has increased significantly in our laboratory and throughout the state since 1985. The results of this test are reported in a novel fashion as multiples of the median. The calculation and reporting of the test results are highly dependent upon gestational age, maternal weight, race and presence or absence of maternal diabetes. When properly interpreted alpha-fetoprotein determinations are a good screening test for early detection of neural tube defects and Trisomy 21 (Down Syndrome). Our approach to screening, diagnosis and counseling is discussed.

UR - http://www.scopus.com/inward/record.url?scp=0024637530&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024637530&partnerID=8YFLogxK

M3 - Article

VL - 74

SP - 55

EP - 58

JO - The Nebraska medical journal

JF - The Nebraska medical journal

SN - 0091-6730

IS - 3

ER -